Serum and cerebrospinal fluid sphingolipids as sensitive measures of demyelination in progressive multiple sclerosis

被引：0
|
作者：
Giovanna, Capodivento [1 ]
Oechtering, Johanna [2 ,3 ,4 ,5 ]
Leppert, David [2 ,3 ,4 ,5 ]
Demuth, Lilian [2 ,3 ,4 ,5 ]
Maceski, Aleksandra Maleska [2 ,3 ,4 ,5 ]
Granziera, Cristina [2 ,3 ,4 ,5 ,6 ]
Lucilla, Nobbio [1 ,7 ]
Kuhle, Jens [2 ,3 ,4 ,5 ]
机构：
[1] IRCCS Osped Policlin San Martino, Genoa, Italy
[2] Univ Basel Hosp, Dept Neurol, Basel, Switzerland
[3] Univ Basel, Basel, Switzerland
[4] Univ Hosp, Multiple Sclerosis Ctr, Basel, Switzerland
[5] Univ Basel Hosp, Dept Biomed & Clin Res, Res Ctr Clin Neuroimmunol & Neurosci RC2NB, Basel, Switzerland
[6] Univ Basel Hosp, Dept Biomed Engn, Translat Imaging Neurol ThINk Basel, Fac Med, Basel, Switzerland
[7] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P250/2124
引用
收藏
页码：313 / 314
页数：2
相关论文
共 50 条
  • [41] Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes
    Jolivet-Reynaud, C
    Perron, H
    Ferrante, P
    Becquart, L
    Dalbon, P
    Mandrand, B
    CLINICAL IMMUNOLOGY, 1999, 93 (03) : 283 - 293
  • [42] Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects
    De Riccardis, L.
    Buccolieri, A.
    Muci, M.
    Pitotti, E.
    De Robertis, F.
    Trianni, G.
    Manno, D.
    Maffia, M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (05): : 1828 - 1838
  • [43] Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis
    Giovannoni, G
    MULTIPLE SCLEROSIS, 1998, 4 (01): : 27 - 30
  • [44] Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
    Dujmovic, Irena
    Pekmezovic, Tatjana
    Obrenovic, Radmila
    Nikolic, Aleksandra
    Spasic, Mihailo
    Stojkovic, Marija Mostarica
    Drulovic, Jelena
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (07) : 848 - 853
  • [45] Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
    Novakova, Lenka
    Axelsson, Markus
    Khademi, Mohsen
    Zetterberg, Henrik
    Blennow, Kaj
    Malmestrom, Clas
    Piehl, Fredrik
    Olsson, Tomas
    Lycke, Jan
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 62 - 71
  • [46] Multiple Cerebrospinal Fluid Bands: Multiple Sclerosis?
    Chen, Yu
    Watts, Gail
    CLINICAL CHEMISTRY, 2011, 57 (07) : 1085 - 1086
  • [47] Cerebrospinal fluid biomarkers in multiple sclerosis
    Tumani, Hayrettin
    Hartung, Hans-Peter
    Hemmer, Bernhard
    Teunissen, Charlotte
    Deisenhammer, Florian
    Giovannoni, Gavin
    Zettl, Uwe K.
    NEUROBIOLOGY OF DISEASE, 2009, 35 (02) : 117 - 127
  • [48] Cerebrospinal fluid proteomics in multiple sclerosis
    Kroksveen, Ann C.
    Opsahl, Jill A.
    Guldbrandsen, Astrid
    Myhr, Kjell-Morten
    Oveland, Eystein
    Torkildsen, Oivind
    Berven, Frode S.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2015, 1854 (07): : 746 - 756
  • [49] The reactions of cerebrospinal fluid in multiple sclerosis
    Achard, C
    Thiers, J
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1922, 107 : 1006 - 1006
  • [50] Cerebrospinal Fluid Testing for Multiple Sclerosis
    Goldsmith, Joshua F.
    Herskovits, A. Zara
    CLINICS IN LABORATORY MEDICINE, 2020, 40 (03) : 369 - +
12345